Loading...
•
Dec 31, 2025
IRadimed Q4 2025 Earnings Report
IRADIMED CORPORATION reported record fourth quarter and full year 2025 financial results, exceeding guidance and increasing its regular quarterly cash dividend.
Key Takeaways
IRADIMED CORPORATION achieved record revenue of $22.7 million in Q4 2025, a 17% increase year-over-year, and reported GAAP diluted EPS of $0.50, up 25%. The company also increased its quarterly cash dividend to $0.20 per share, reflecting confidence in future business outlook.
Record Q4 2025 revenue of $22.7 million, a 17% increase compared to Q4 2024.
Record Q4 2025 GAAP diluted EPS of $0.50, a 25% increase compared to Q4 2024.
Record Q4 2025 non-GAAP diluted EPS of $0.54, a 23% increase compared to Q4 2024.
Quarterly cash dividend increased to $0.20 per share from $0.17 per share.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
For the first quarter of 2026, IRADIMED expects revenue between $21.0 million and $22.0 million, GAAP diluted EPS between $0.39 and $0.43, and non-GAAP diluted EPS between $0.44 and $0.48. For the full year 2026, revenue is projected to be between $91.0 million and $96.0 million, GAAP diluted EPS between $1.90 and $2.05, and non-GAAP diluted EPS between $2.06 and $2.21.
Positive Outlook
- Expected full year 2026 revenue growth with a range of $91.0 million to $96.0 million.
- Anticipated full year 2026 GAAP diluted EPS between $1.90 and $2.05.
- Projected full year 2026 non-GAAP diluted EPS between $2.06 and $2.21.
- First quarter 2026 revenue guidance of $21.0 million to $22.0 million.
- First quarter 2026 non-GAAP diluted EPS guidance of $0.44 to $0.48.
Challenges Ahead
- Stock-based compensation expense, net of tax, is expected to be approximately $0.6 million for Q1 2026.
- Stock-based compensation expense, net of tax, is expected to be approximately $2.0 million for the full year 2026.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...